PERFUZE
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative catheter technology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in s... afe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
PERFUZE
Social Links:
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2018-01-01
Address:
Newcastle, Galway, Ireland
Country:
Ireland
Website Url:
http://www.perfuze.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
25.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Google Maps ReCAPTCHA AJAX Libraries API ReCAPTCHA V2
Similar Organizations
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Current Advisors List
Current Employees Featured
Founder
Investors List
SV Health Investors
SV Health Investors investment in Series A - Perfuze
HBM-MedFocus
HBM-MedFocus investment in Series A - Perfuze
Seroba Life Sciences
Seroba Life Sciences investment in Series A - Perfuze
Life Sciences Partners
Life Sciences Partners investment in Series A - Perfuze
EarlyBird
EarlyBird investment in Series A - Perfuze
Enterprise Ireland
Enterprise Ireland investment in Series A - Perfuze
EarlyBirdCapital
EarlyBirdCapital investment in Seed Round - Perfuze
Enterprise Ireland
Enterprise Ireland investment in Seed Round - Perfuze
MedFocus Fund
MedFocus Fund investment in Seed Round - Perfuze
Official Site Inspections
http://www.perfuze.com Semrush global rank: 7.24 M Semrush visits lastest month: 548
- Host name: 89.234.32.54
- IP address: 89.234.32.54
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Perfuze"
Perfuze - Crunchbase Company Profile & Funding
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience …See details»
Perfuze Company Profile 2024: Valuation, Funding & Investors
Perfuze General Information Description. Operator of a medical device company designed to treat acute ischemic stroke in patients. The company provides clinical outcomes in short procedural …See details»
Meet our innovative and dynamic team at Perfuze
Meet the Team at Perfuze are developing innovative medical technology devices to treat stroke at our offices in Galway.See details»
Perfuze Company Profile - Office Locations, Competitors ... - Craft
Perfuze has 5 employees at their 1 location and $3.43 m in total funding,. See insights on Perfuze including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Perfuze - eqtgroup.com
Oct 24, 2024 perfuze.com. Latest news. 05 November 2024 EQT X, through Oak BidCo S.à r.l., has secured an ownership of 72.5% of the votes in OEM International Aktiebolag (publ) and …See details»
Perfuze - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Feb 9, 2022 ... EQT Life …See details»
Perfuze - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Perfuze . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Perfuze has 5 board members and …See details»
Irish medtech company Perfuze raises €22.5m for new …
Feb 9, 2022 Galway-based medtech company Perfuze has raised €22.5 million in funding for the development of a new stroke treatment. Founded by Wayne Allen and Liam Mullins in 2018, two years after they sold ...See details»
Neurovascular Company Perfuze Raises €22.5m ($25m) Series
Feb 9, 2022 GALWAY, Ireland--(BUSINESS WIRE)-- Perfuze, a medical device company developing next-generation catheter-based aspiration technology to treat large vessel …See details»
Neurovascular Company Perfuze Raises €22.5m ($25m) …
Feb 9, 2022 Perfuze was founded in 2018 by Wayne Allen and Liam Mullins, who have over 35 years combined medtech experience. This is the second medtech company they have co-founded; the previous company, Embo ...See details»
Irish medtech Perfuze raises €22.5m for stroke treatment device
Feb 9, 2022 Perfuze is developing catheter-based technology to remove blood clots from the brain and treat acute ischemic stroke. Galway-based medtech start-up Perfuze has raised …See details»
Latest news and updates for Perfuze Ltd in Galway Ireland
Perfuze Raises €22.5m. Read More . May 2021. Perfuze secures CE Mark on first product First five patients successfully treated. Read More . March 2021. Published paper - JNIS Millipede …See details»
Perfuze raises €22.5m in Series A funding for novel acute …
Feb 9, 2022 According to the World Health Organization (WHO), stroke is the second leading global cause of death and a leading cause of disability, the release adds. Perfuze’s next …See details»
FDA grants breakthrough status to Perfuze stroke device
Aug 8, 2019 Perfuze raised roughly $3 million in seed funding earlier this year but faces the challenge of entering a field currently fought over by companies including Johnson & Johnson, …See details»
Perfuze® Announces FDA Clearances for Novel Neurovascular …
GALWAY, Ireland, December 20, 2023--Perfuze, a private medical device company dedicated to developing pioneering technology to treat acute ischemic stroke, proudly announces FDA …See details»
Perfuze® Announces First Stroke Patient Enrolled in the MARRS …
Nov 2, 2023 The Perfuze Millipede 088 Access Catheter received U.S. FDA 510(k) clearance for neurovascular access in 2022, and CE Mark for first-line aspiration thrombectomy in the …See details»
PERFUZE: Receives Breakthrough Device Designation Status
Aug 9, 2019 An ischemic stroke occurs when a blood vessel in the brain is blocked by a clot, preventing blood flow. Perfuze’s technology aims to provide superior clinical outcomes in …See details»
Acute Ischemic Stroke Treatment Techniques | Perfuze
Acute ischemic stroke is a condition where the blood supply to the brain is disrupted, resulting in oxygen starvation, brain damage and loss of function.See details»
Perfuze® announces FDA clearances for novel neurovascular …
Dec 20, 2023 Perfuze, a private medical device company dedicated to developing pioneering technology to treat acute ischemic stroke, proudly announces FDA clearance for the Millipede …See details»